Krishna Institute of Medical Sciences Ltd Share Price

2,121.5
(0.30%)
Jul 24, 2024|03:32:26 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2,123.45
  • Day's High2,140
  • 52 Wk High2,356.4
  • Prev. Close2,115.1
  • Day's Low2,106.05
  • 52 Wk Low1,750
  • Turnover (lac)690.78
  • P/E71.93
  • Face Value10
  • Book Value233.19
  • EPS29.41
  • Mkt. Cap (Cr.)16,977.9
  • Div. Yield0
No Records Found

Krishna Institute of Medical Sciences Ltd KEY RATIOS

Sector

Healthcare

Open

2,123.45

Prev. Close

2,115.1

Turnover(Lac.)

690.78

Day's High

2,140

Day's Low

2,106.05

52 Week's High

2,356.4

52 Week's Low

1,750

Book Value

233.19

Face Value

10

Mkt Cap (₹ Cr.)

16,977.9

P/E

71.93

EPS

29.41

Divi. Yield

0

Krishna Institute of Medical Sciences Ltd Corporate Action

24 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

18 May 2023

12:00 AM

AGM

Announcement Date: 18 May, 2023

arrow

Krishna Institute of Medical Sciences Ltd NEWS AND UPDATE

KIMS acquires Visakhapatnam Hospital in ₹75 Crore deal
10 Jul 2024|03:29 PM

It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Krishna Institute of Medical Sciences Ltd SHAREHOLDING SNAPSHOT

24 Jul, 2024|12:18 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 38.81%

Foreign: 0.00%

Indian: 38.81%

Non-Promoter- 49.96%

Institutions: 49.96%

Non-Institutions: 11.21%

Custodian: 0.00%

Share Price

Krishna Institute of Medical Sciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

80.03

80.03

77.59

74.8

Preference Capital

0

0

0

0

Reserves

1,550.83

1,297.52

829.73

549.33

Net Worth

1,630.86

1,377.55

907.32

624.13

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021

Revenue

1,143.37

932.68

yoy growth (%)

22.58

Raw materials

-249.9

-201.19

As % of sales

21.85

21.57

Employee costs

-174.02

-147.03

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021

Profit before tax

371

254.26

Depreciation

-44.92

-44.59

Tax paid

-92.63

-65.61

Working capital

-27.52

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021

Growth matrix (%)

Revenue growth

22.58

Op profit growth

30.32

EBIT growth

39.55

Net profit growth

47.55

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

2,498.14

2,197.68

1,650.83

1,329.94

1,122.65

Excise Duty

0

0

0

0

0

Net Sales

2,498.14

2,197.68

1,650.83

1,329.94

1,122.65

Other Operating Income

0

0

0

0

0

Other Income

13.06

40.7

29.77

10.17

6.08

Krishna Institute of Medical Sciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,403.6

91.1692,119.95238.80.091,894.6536.28

Max Healthcare Institute Ltd

MAXHEALTH

935.1

132.2890,893.25241.770.16610.1179.02

Fortis Healthcare Ltd

FORTIS

487.2

297.2336,800.4368.330.21307.48120.36

Global Health Ltd

MEDANTA

1,176.3

87.7831,633.5492.240578.65106.08

Syngene International Ltd

SYNGENE

757.75

65.2930,488.15189.80.16864.7104.14

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Krishna Institute of Medical Sciences Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director

Bhaskara Rao Bollineni

Executive Director & CEO

Abhinay Bollineni

WTD & Executive Director

Dandamudi Anitha

Independent Non Exe. Director

Rajeswara Rao Gandu

Independent Non Exe. Director

Saumen Chakraborty

Independent Non Exe. Director

Pankaj Vaish

Independent Non Exe. Director

Ratna Kishore Kaza

Independent Non Exe. Director

J V Ramudu

Independent Non Exe. Director

Y Prameela Rani

Non Executive Director

Shantanu Rastogi

Independent Director

Y Prameela Rani

Additional Director

Adwik Bollineni

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Krishna Institute of Medical Sciences Ltd

Summary

Krishna Institute of Medical Sciences Limited (KIMS) was incorporated as Jagjit Singh and Sons Private Limited, a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, name of the Company was changed to Krishna Institute of Medical Sciences Private Limited on January 2, 2004. Pursuant to the conversion of Company to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It operate 12 multispecialty hospitals under the KIMS Hospitals brand, with an aggregate capacity of over 4,000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company.Led by Dr. Bhas
Read More

Company FAQs

What is the Krishna Institute of Medical Sciences Ltd share price today?

Down Arrow

The Krishna Institute of Medical Sciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹2121.5 today.

What is the Market Cap of Krishna Institute of Medical Sciences Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krishna Institute of Medical Sciences Ltd is ₹16977.90 Cr. as of 24 Jul ‘24

What is the PE and PB ratio of Krishna Institute of Medical Sciences Ltd?

Down Arrow

The PE and PB ratios of Krishna Institute of Medical Sciences Ltd is 71.93 and 9.07 as of 24 Jul ‘24

What is the 52 Week High and Low of Krishna Institute of Medical Sciences Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Krishna Institute of Medical Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Krishna Institute of Medical Sciences Ltd is ₹1750 and ₹2356.4 as of 24 Jul ‘24

What is the CAGR of Krishna Institute of Medical Sciences Ltd?

Down Arrow

Krishna Institute of Medical Sciences Ltd's CAGR for 5 Years at 16.23%, 3 Years at 20.22%, 1 Year at 10.94%, 6 Month at 4.85%, 3 Month at 5.73% and 1 Month at 2.93%.

What is the shareholding pattern of Krishna Institute of Medical Sciences Ltd?

Down Arrow

The shareholding pattern of Krishna Institute of Medical Sciences Ltd is as follows:
Promoters - 38.82 %
Institutions - 49.96 %
Public - 11.22 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.